Fox Chase Cancer Center Chooses Progenesis

Fox Chase Cancer Center Chooses Progenesis from Nonlinear Dynamics for Proteomics Research

(Newcastle upon Tyne, UK and Philadelphia, PA) Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, announced that Fox Chase Cancer Center has chosen Progenesis as the automated solution for its proteomics research.The leading cancer research facility uses 2D gel electrophoresis technology for its protein studies, and generating reliable data from these 2D gels is crucial to the success of any project. Progenesis provides a totally new concept in automation. It is a unique, scalable solution that tackles the well-documented problems associated with 2D gel electrophoresis analysis, giving fast, accurate and reproducible results.

Steven Seeholzer, staff scientist at Fox Chase Cancer Center, said, "The analysis stage of 2D electrophoresis has always represented a major bottleneck in proteomic research. We have evaluated various options to overcome these issues and as a result first purchased Phoretix 2D Advanced, until now the clear leader in 2D gel analysis. But now we have recognised the clear advantage of Progenesis." He added, "This new product enables us to achieve new levels of throughput, providing a level of reliability and accuracy and objectivity we have never before seen."

Bob Marchmont, president of Nonlinear USA Inc., said, "We are delighted that such a well-respected cancer center as Fox Chase has become a Progenesis customer. Progenesis truly represents a breakthrough in 2D gel analysis, changing the landscape of proteomic possibilities. We are looking forward to working with Fox Chase to help to realise this potential within the Center's research." He added, "Close collaboration with our customers is paramount to us. We are continuing to invest heavily in our US subsidiary in order to provide the highest quality of support to our customers throughout the United States."

About Fox Chase Cancer Center

Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach.

About Nonlinear Dynamics Ltd

Nonlinear Dynamics develops proteomics analysis software that is different, ground-breaking and above all designed to help you generate reliable conclusions that are reproducible across labs. Our new way of thinking has been applied to LCMS, MALDI and 2D data analysis so you can make a real difference using a combination of the right techniques, your expertise and the Progenesis software. The TotalLab laboratory products for 1D gel analysis provide quick and simple quantitation through to in-depth lane relationship studies, as well as offering features for research that requires 21CFR part 11 compliance.

"Everything about Nonlinear Dynamics makes it a great company to work with..."
Merry L. Lindsey, Ph.D., Assistant Professor
University of Texas Health Science Center at San Antonio

Nonlinear sells and supports its products through its UK headquarters and its USA office, as well as a global network of partners and OEM resellers.

Contact: Beth Rossiter, Marketing Department
Email: beth.rossiter@nonlinear.com
Tel: +44 (0)191 230 2121

Released: 16 August 2001

Current press releases | Archive press releases